the new study, published this week in the journal of medical screening , was conducted by researchers from the university of toronto, university of ottawa, university of british columbia, university of alberta, and harvard university; it suggests that there are serious problems in the randomization aspect, including many issues in the screening trial.
advertisement
“ in addition to other serious flaws that have been documented elsewhere, there is now direct eyewitness evidence available of subversion of randomization of the cnbss and the systematic inclusion of symptomatic individuals,” the new study reads. “cnbss 1 and 2 were not reliably randomized controlled trials, nor were they truly trials of screening.”
cnbss 1 and 2 refers to sets of data collected in 1995 and 2014, which excluded deaths that occurred from cancers detected in the prevalence screening.
dr. jean seely, a professor of radiology at the university of ottawa, head of breast imaging at the ottawa hospital, and one of the authors of the new study, called for women age 40 and up to get regular mammograms in an interview with cbc news.
advertisement
since originally being published, the cnbss study has been widely criticized as misleading due to those factors. the american college of radiology and society of breast imaging previously issued a statement criticizing the study, calling it “an incredibly misleading analysis based on the deeply flawed and widely discredited canadian national breast screening study.”
“ future trials should avoid the weaknesses in design methodology and should contain effective measures to prevent the flaws in execution that were found in cnbss 1 and 2,” the new study reads.
in 2021, more than 27,000 women in canada will be diagnosed with breast cancer, the canadian cancer society says. that figure makes up one-quarter of all cancer diagnoses nationally. of those, 5,400 will die, representing 13 per cent of all cancer deaths in women annually.